Centerpoint Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Sell
218
-1
-0.5% -$104 0.01% 246
2026
Q1
$21K Buy
219
+39
+22% +$4K 0.01% 228
2025
Q4
$19K Hold
180
0.01% 258
2025
Q3
$23K Sell
180
-1
-0.6% -$119 0.01% 228
2025
Q2
$22K Sell
181
-118
-39% -$13.5K 0.01% 221
2025
Q1
$30K Hold
299
0.01% 195
2024
Q4
$28K Hold
299
0.01% 216
2024
Q3
$29K Hold
299
0.01% 222
2024
Q2
$26K Sell
299
-3
-1% -$252 0.01% 227
2024
Q1
$25K Hold
302
0.01% 218
2023
Q4
$20K Hold
302
0.01% 233
2023
Q3
$20K Sell
302
-1
-0.3% -$69 0.01% 226
2023
Q2
$21K Hold
303
0.01% 238
2023
Q1
$16K Buy
303
+43
+17% +$2.5K 0.01% 297
2022
Q4
$16K Buy
+260
New +$14.1K 0.01% 235

Other funds holding EHC

Centerpoint Advisors's EHC Position: Q2 2026 in Review

Centerpoint Advisors reduced its Encompass Health (EHC) stake by 0.46% in Q2 2026, selling an estimated $104 and leaving 218 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #246.

Centerpoint Advisors first reported a position in EHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $30K in Q1 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Centerpoint Advisors held 218 shares of Encompass Health worth $22K as of Q2 2026.
  • Centerpoint Advisors sold 1 Encompass Health share in Q2 2026, an estimated $104.
  • Encompass Health made up 0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #246 holding.
  • Centerpoint Advisors first reported a position in Encompass Health in Q4 2022 and has held it in 15 quarters since.
  • Centerpoint Advisors's Encompass Health position peaked at $30K in Q1 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.